OSIR - MiMedx Group Is More Than Just A Restatement Play With An Enormous Hidden Asset In Osteo-Arthritis
Editor's note: Seeking Alpha is proud to welcome FIN Capital Management LLC as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more »
BACKGROUND: MiMedx Group (OTC:MDXG) is a biopharmaceutical company that develops biologics using placental and amniotic allografts. During the JPM healthcare conference of 2018, short seller Marc Cohodes confronted the management team over the company’s sales practices, launching the opening salvos of what would end up